These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Selection of a new generation of orally active alpha-ketohydroxypyridine iron chelators intended for use in the treatment of iron overload. Kontoghiorghes GJ, Barr J, Nortey P, Sheppard L. Am J Hematol; 1993 Apr; 42(4):340-9. PubMed ID: 8493983 [Abstract] [Full Text] [Related]
5. The effect of 2,4-dihydroxypyridine-N-oxide, a new orally active iron chelator, on iron excretion in mice. Kontoghiorghes GJ. Clin Chim Acta; 1987 Mar 16; 163(2):137-41. PubMed ID: 3568416 [Abstract] [Full Text] [Related]
8. Release of iron from phagocytosed Escherichia coli and uptake by neutrophil lactoferrin. Molloy AL, Winterbourn CC. Blood; 1990 Feb 15; 75(4):984-9. PubMed ID: 2154270 [Abstract] [Full Text] [Related]
9. Effect of novel 1-alkyl-3-hydroxy-2-methylpyrid-4-one chelators on uptake and release of iron from macrophages. Brock JH, Licéaga J, Arthur HM, Kontoghiorghes GJ. Am J Hematol; 1990 May 15; 34(1):21-5. PubMed ID: 2327400 [Abstract] [Full Text] [Related]
10. The effect of zinc on [59Fe]lactoferrin binding to blood neutrophilic leucocytes and colostral cells. Maneva AI, Manev VV, Sirakov LM. Int J Biochem; 1984 May 15; 16(7):793-7. PubMed ID: 6088318 [Abstract] [Full Text] [Related]
20. Relationships between iron and vanadium metabolism: the association of vanadium with bovine lactoferrin. Sabbioni E, Rade J. Toxicol Lett; 1980 May 16; 5(6):381-7. PubMed ID: 7394833 [Abstract] [Full Text] [Related] Page: [Next] [New Search]